Five Prime Therapeutics Obtains $10,000,000 New Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=867b7650-9443-4850-a7a1-dafe58f94013&Preview=1 - Date
4/20/2012 - Company Name
Five Prime Therapeutics - Mailing Address
Two Corporate Dr South San Francisco, CA 94080 - Company Description
FivePrime is a drug discovery and development company primarily focused on therapeutic proteins. The Company is creating a new paradigm in drug discovery by leveraging the Pharmanome(TM) – the entire set of pharmaceutically relevant genes and proteins. - Website
http://www.fiveprime.com - Transaction Type
Venture Equity - Transaction Amount
$10,000,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
